These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 353658)

  • 1. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
    Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function.
    Ponari O; Civardi E; Dettori G; Magha A; Potì R; Bulletti G
    Arzneimittelforschung; 1976; 26(8):1532-8. PubMed ID: 12770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of antithrombotic properties of sodium ibuprofen.
    Esquivel CO; Bergqvist D; Björck CG; Carson SN; Nilsson B
    Thromb Haemost; 1982 Aug; 48(1):87-90. PubMed ID: 7135348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence on haemostasis exercised by Prostaglandin F2alpha in missed abortion (author's transl)].
    Briel RC; Kunz S; Kidess E
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):862-7. PubMed ID: 700348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clotting and fibrinolysis.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():50-3. PubMed ID: 182726
    [No Abstract]   [Full Text] [Related]  

  • 10. Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
    Tomikawa M
    Thromb Diath Haemorrh; 1975 Sep; 34(1):145-58. PubMed ID: 1188708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of recombinant staphylokinase and streptokinase on platelet aggregation.
    Abdelouahed M; Hatmi M; Helft G; Emadi S; Elalamy I; Samama MM
    Thromb Haemost; 1997 May; 77(5):815-7. PubMed ID: 9184383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of platelet function, coagulation and fibrinolysis during induction of labour at term by prostaglandin F2alpha and oxytocin (author's transl)].
    Briel RC; Kidess E; Kunz S
    Z Geburtshilfe Perinatol; 1978 Jun; 182(3):238-42. PubMed ID: 80063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.
    Niewiarowski S; Senyi AF; Gillies P
    J Clin Invest; 1973 Jul; 52(7):1647-59. PubMed ID: 4268896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.